Patient Reported Outcome Measures (PROMs) With Trabectedin
A Pilot Study of Patient Reported Outcomes When Treated With Trabectedin for Unresectable and/or Metastatic Soft Tissue Sarcoma
Sponsor: University of Leeds
Terminated
Insufficient accrual
Other terminated trials from University of Leeds
Other Leiomyosarcoma trials with similar outcome
Listed as NCT03959033, this observational or N/A phase trial focuses on Leiomyosarcoma and Liposarcoma and remains terminated or withdrawn. Sponsored by University of Leeds, it has been updated 6 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Sep 2022 — Jul 2024 [monthly]
Terminated
Status: Unknown Status → Terminated
-
Oct 2021 — Sep 2022 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
▶ Show 1 earlier version
-
Jun 2019 — Jan 2021 [monthly]
Recruiting
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Leeds
For direct contact, visit the study record on ClinicalTrials.gov .